PHARMACOLOGY OF INTRAPERITONEAL CHEMOTHERAPY

被引:76
作者
MYERS, CE [1 ]
COLLINS, JM [1 ]
机构
[1] NCI, DIV RES SERV, BETHESDA, MD 20205 USA
关键词
D O I
10.3109/07357908309048508
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
引用
收藏
页码:395 / 407
页数:13
相关论文
共 59 条
[1]  
ADAMS GE, 1981, CANCER, V48, P696, DOI 10.1002/1097-0142(19810801)48:3<696::AID-CNCR2820480307>3.0.CO
[2]  
2-V
[3]  
Babb A L, 1973, Proc Eur Dial Transplant Assoc, V10, P247
[4]  
BERGERAT JP, 1981, CANCER RES, V41, P25
[6]   PROGNOSIS AND TREATMENT OF ENDOMETRIAL CANCER [J].
BERMAN, ML ;
BALLON, SC ;
LAGASSE, LD ;
WATRING, WG .
AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 1980, 136 (05) :679-688
[7]   THRESHOLD METHOTREXATE CONCENTRATION FOR IN-VIVO INHIBITION OF DNA-SYNTHESIS IN NORMAL AND TUMOROUS TARGET TISSUES [J].
CHABNER, BA ;
YOUNG, RC .
JOURNAL OF CLINICAL INVESTIGATION, 1973, 52 (08) :1804-1811
[8]  
CLARKSON B, 1964, CLIN PHARMACOL THER, V5, P581
[9]  
CLEMENT JJ, 1980, CANCER RES, V40, P4165
[10]   NON-LINEAR PHARMACOKINETIC MODELS FOR 5-FLUOROURACIL IN MAN - INTRAVENOUS AND INTRAPERITONEAL ROUTES [J].
COLLINS, JM ;
DEDRICK, RL ;
KING, FG ;
SPEYER, JL ;
MYERS, CE .
CLINICAL PHARMACOLOGY & THERAPEUTICS, 1980, 28 (02) :235-246